XML 53 R38.htm IDEA: XBRL DOCUMENT
v3.25.1

Intangible Assets (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2025
Intangible Assets, Net (Excluding Goodwill) [Abstract] |
Schedule of Reconciliation of the Activity Affecting Intangible Assets | A reconciliation of the activity affecting intangible assets, net for each of 2025 and 2024 is as follows:
| Year Ended March 31, 2025
(In thousands) | Indefinite- Lived Tradenames |  | Finite-Lived Tradenames and Customer Relationships |  | Totals
Gross Carrying Amounts |  |  |  |  |
Balance – March 31, 2024 | $ | 2,167,162 |  |  | $ | 411,258 |  |  | $ | 2,578,420 |
Additions (a) | 6,850 |  |  | 1,400 |  |  | 8,250 |
Reclassifications (b) | (28,982) |  |  | 28,982 |  |  | — |
Tradename impairment | (6,552) |  |  | (5,914) |  |  | (12,466) |
Effects of foreign currency exchange rates | (1,492) |  |  | (1,226) |  |  | (2,718) |
Balance – March 31, 2025 | $ | 2,136,986 |  |  | $ | 434,500 |  |  | $ | 2,571,486 |
Accumulated Amortization |  |  |  |  |
Balance – March 31, 2024 | $ | — |  |  | $ | 257,837 |  |  | $ | 257,837 |
Additions | — |  |  | 18,263 |  |  | 18,263 |
Effects of foreign currency exchange rates | — |  |  | 36 |  |  | 36 |
Balance – March 31, 2025 | $ | — |  |  | $ | 276,136 |  |  | $ | 276,136 |
Intangible assets, net – March 31, 2025 | $ | 2,136,986 |  |  | $ | 158,364 |  |  | $ | 2,295,350 |
Intangible Assets, net by Reportable Segment: |  |  |  |  |
North American OTC Healthcare | $ | 2,068,752 |  |  | $ | 141,234 |  |  | $ | 2,209,986 |
International OTC Healthcare | 68,234 |  |  | 17,130 |  |  | 85,364 |
Intangible assets, net – March 31, 2025 | $ | 2,136,986 |  |  | $ | 158,364 |  |  | $ | 2,295,350 |
(a) Amounts relate to our acquisition of Hydralyte intellectual property on October 1, 2024, giving us the rights to the Hydralyte intellectual property in all remaining jurisdictions with the exception of the United States. (b) In connection with our annual impairment test at February 28, 2025, certain indefinite-lived intangible assets were moved to finite-lived to better reflect our long-term projections for these brands.
| Year Ended March 31, 2024
(In thousands) | Indefinite- Lived Tradenames |  | Finite-Lived Tradenames and Customer Relationships |  |  | Totals
Gross Carrying Amounts |  |  |  |  |  |
Balance – March 31, 2023 | $ | 2,168,902 |  |  | $ | 411,118 |  |  |  | $ | 2,580,020 |
Additions (a) | 393 |  |  | 680 |  |  |  | 1,073 |
Effects of foreign currency exchange rates | (2,133) |  |  | (540) |  |  |  | (2,673) |
Balance – March 31, 2024 | $ | 2,167,162 |  |  | $ | 411,258 |  |  |  | $ | 2,578,420 |
Accumulated Amortization |  |  |  |  |  |
Balance – March 31, 2023 | $ | — |  |  | $ | 238,127 |  |  |  | $ | 238,127 |
Additions | — |  |  | 19,784 |  |  |  | 19,784 |
Effects of foreign currency exchange rates | — |  |  | (74) |  |  |  | (74) |
Balance – March 31, 2024 | $ | — |  |  | $ | 257,837 |  |  |  | $ | 257,837 |
Intangible assets, net – March 31, 2024 | $ | 2,167,162 |  |  | $ | 153,421 |  |  |  | $ | 2,320,583 |
Intangible Assets, net by Reportable Segment: |  |  |  |  |  |
North American OTC Healthcare | $ | 2,092,853 |  |  | $ | 135,932 |  |  |  | $ | 2,228,785 |
International OTC Healthcare | 74,309 |  |  | 17,489 |  |  |  | 91,798 |
Intangible assets, net – March 31, 2024 | $ | 2,167,162 |  |  | $ | 153,421 |  |  |  | $ | 2,320,583 |
(a) On January 8, 2024, our Australian subsidiary acquired one of its suppliers. In connection with this acquisition, we allocated $1.1 million to intangible assets.
Schedule of Expected Amortization Expense | At March 31, 2025, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of 10 to 24 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):
(In thousands) |
Year Ending March 31, | Amount
2026 | $ | 17,192 |
2027 | 15,602 |
2028 | 13,277 |
2029 | 13,277 |
2030 | 13,277 |
Thereafter | 85,739 |
| $ | 158,364 |

X
- Definition Schedule of Intangible Assets [Table Text Block] + References No definition available. + Details
Name: | pbh_ScheduleOfIntangibleAssetsTableTextBlock
Namespace Prefix: | pbh_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 55 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration